Celgene News

$6.4 Billion Suit Claims Bristol-Myers Delayed Cancer Drug to Avoid Shareholder Payment

Bristol Myers Squibb Co. was sued for $6.4 billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp., which the drugmaker bought in 2019. According to a complaint in Manhattan …

Pennsylvania Man Recruited by Soccer Pro Admits Military Insurance Fraud

A man admitted in federal court in New Jersey on Wednesday that he defrauded a military insurance program after he was recruited into the scheme by a former Major League Soccer TV analyst. Jason Cerge, 41, of Media, Penn., pleaded …